IRON Projected Dividend Yield
Disc Medicine Inc ( NASDAQ : IRON )Disc Medicine is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of treatments for patients suffering from hematologic diseases. Co.'s pipeline includes: bitopertin for the treatment of erythropoietic porphyrias including erythropoietic protoporphyria, X-linked protoporphyria, and Diamond-Blackfan Anemia; DISC-0974 for the treatment of anemia of myelofibrosis and anemia of chronic kidney disease; and MWTX-003 for the treatment of polycythemia vera, and other hematologic disorders. In addition, Co.'s preclinical programs also include DISC-0998, for the treatment of anemia associated with inflammatory diseases. 20 YEAR PERFORMANCE RESULTS |
IRON Dividend History Detail IRON Dividend News IRON Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |